Accenture PLC (ACN) is not a good buy at the moment for a beginner investor with a long-term focus. The stock has experienced a significant price drop of nearly 18% due to weaker-than-expected Q3 results, reduced FY2026 revenue guidance, and ongoing concerns about AI-related revenue cannibalization and demand headwinds. The technical indicators are bearish, and while the stock is oversold, there are no strong positive catalysts or trading signals to suggest an immediate recovery. Additionally, Congress trading data shows more selling activity, indicating caution. For long-term investors, it may be prudent to wait for more clarity on the company's growth trajectory and stabilization in its financial performance.
The MACD is negative and expanding (-3.892), indicating bearish momentum. The RSI is at 7.809, signaling oversold conditions. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key support levels (S1: 135.908, S2: 122.32).

The company is committed to returning $2.2 billion to shareholders.
The company lowered its FY2026 revenue growth forecast from 3-5% to 3-4%. Analysts have downgraded the stock, citing slowing bookings, demand headwinds, and AI-related revenue cannibalization. A securities investigation has been launched over potentially misleading revenue outlook statements. Congress trading data shows more selling activity than buying.
Accenture's Q3 revenue was $18.7 billion, a 6% year-over-year increase, but it fell short of analyst expectations. EPS grew by 9%, and the company plans to return $2.2 billion to shareholders. However, the reduced FY2026 revenue guidance and slowing bookings indicate weaker forward demand.
Several analysts have downgraded the stock, with price targets lowered significantly (e.g., Baird: $190 from $265, Evercore ISI: $180 from $250, Morgan Stanley: $177 from $240). The consensus reflects concerns over slowing demand, AI-related disruptions, and geopolitical uncertainties.